Michel Detheux appointed CEO of Muna Therapeutics, GSK Alzheimer’s partner, as Genentech loses scientist Alex Hoffman
read at Endpoints ↗Neutral
Michel Detheux has taken over as chief executive of Danish neuro‑biotech Muna Therapeutics, succeeding Rita Balice‑Gordon in the role.
Muna Therapeutics continues its collaboration with GlaxoSmithKline, focusing on the development of treatments for Alzheimer’s disease under the new leadership.
In a separate move, Genentech announced the departure of a key scientist, Alex Hoffman, marking another loss for the company’s research team.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist”
read at Endpoints ↗84 words · retrieved Jul 2
comments(0)
5-min edit window · permanent after that